Workflow
Estimate Revisions
icon
Search documents
Equity Bancshares (EQBK) Upgraded to Buy: Here's What You Should Know
ZACKS· 2025-07-18 17:01
Equity Bancshares (EQBK) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Since a changin ...
Samsara Inc. (IOT) Upgraded to Strong Buy: Here's What You Should Know
ZACKS· 2025-07-18 17:01
Samsara Inc. (IOT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changing earni ...
Strength Seen in StepStone Group (STEP): Can Its 6.0% Jump Turn into More Strength?
ZACKS· 2025-07-18 16:05
Group 1 - StepStone Group Inc. (STEP) shares increased by 6% to close at $63.24, with a notable trading volume compared to normal sessions, and an overall gain of 11.3% over the past four weeks [1][2] - The price surge was driven by the announcement that StepStone is leveraging Goji's technology to improve access to its European private market evergreen funds, enhancing the investor experience [2] - The company is projected to report quarterly earnings of $0.41 per share, reflecting a year-over-year decline of 14.6%, while revenues are expected to reach $228.81 million, a 3.5% increase from the previous year [3] Group 2 - The consensus EPS estimate for StepStone has remained stable over the last 30 days, indicating that stock price movements may not sustain without earnings estimate revisions [4] - StepStone Group holds a Zacks Rank of 1 (Strong Buy), suggesting strong market confidence in the stock's potential [4] - The company operates within the Zacks Financial - Miscellaneous Services industry, which includes other firms like Houlihan Lokey, whose stock has also shown positive performance [4][5]
American Express (AXP) Tops Q2 Earnings and Revenue Estimates
ZACKS· 2025-07-18 15:35
American Express (AXP) came out with quarterly earnings of $4.08 per share, beating the Zacks Consensus Estimate of $3.86 per share. This compares to earnings of $3.49 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +5.70%. A quarter ago, it was expected that this credit card issuer and global payments company would post earnings of $3.45 per share when it actually produced earnings of $3.64, delivering a surprise of +5.51%.Ov ...
Strength Seen in Ambac (AMBC): Can Its 17.7% Jump Turn into More Strength?
ZACKS· 2025-07-18 14:50
Ambac Financial Group (AMBC) shares soared 17.7% in the last trading session to close at $8.65. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 6.2% gain over the past four weeks.Ambac shares surged after the Wisconsin Office of the Commissioner of Insurance scheduled a hearing on the sale of Ambac Assurance Corporation. This is considered one of the final steps in the Wisconsin regulatory approval process. Ambac's president and ...
Down 10.0% in 4 Weeks, Here's Why New Gold (NGD) Looks Ripe for a Turnaround
ZACKS· 2025-07-18 14:36
New Gold (NGD) has been beaten down lately with too much selling pressure. While the stock has lost 10% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price mov ...
Exploring Analyst Estimates for Boston Scientific (BSX) Q2 Earnings, Beyond Revenue and EPS
ZACKS· 2025-07-18 14:15
Core Viewpoint - Boston Scientific (BSX) is expected to report quarterly earnings of $0.72 per share, reflecting a 16.1% increase year-over-year, with revenues projected at $4.89 billion, an 18.7% increase compared to the previous year [1]. Financial Performance Estimates - Analysts anticipate 'Net Sales- MedSurg- Worldwide' to reach $1.68 billion, indicating a 13.1% increase from the prior-year quarter [4]. - The estimated 'Net Sales- Cardiovascular- Worldwide' is projected at $3.21 billion, representing a 21.7% increase year-over-year [4]. - 'Net Sales- Cardiovascular- Cardiology- Worldwide' is expected to be $2.52 billion, showing a 23.3% increase from the previous year [5]. - 'Net Sales- Cardiovascular- Peripheral Interventions- Worldwide' is forecasted at $689.56 million, indicating a 16.9% year-over-year change [5]. - 'Geographic Revenue- U.S.' is likely to reach $3.06 billion, reflecting a 24.1% increase year-over-year [6]. - 'Net Sales- Cardiovascular- Peripheral Interventions- International' is projected at $309.92 million, indicating a 10.3% increase from the prior year [6]. - 'Net Sales- MedSurg- Neuromodulation- United States' is expected to be $220.82 million, showing a 3.2% increase year-over-year [7]. - 'Net Sales- MedSurg- Neuromodulation- International' is forecasted at $70.31 million, reflecting a 3.4% increase [7]. - 'Net Sales- MedSurg- Endoscopy- United States' is projected at $445.09 million, indicating a 7.3% increase year-over-year [8]. - 'Net Sales- MedSurg- Endoscopy- International' is expected to reach $273.79 million, reflecting a 4.9% increase [8]. - 'Net Sales- MedSurg- Urology- United States' is forecasted at $492.40 million, indicating a significant 35.7% increase year-over-year [8]. - 'Net Sales- MedSurg- Urology- International' is projected at $177.83 million, reflecting a 9.8% increase [9]. Market Performance - Over the past month, shares of Boston Scientific have returned +3.2%, compared to the Zacks S&P 500 composite's +5.4% change [9]. - Currently, BSX holds a Zacks Rank 2 (Buy), suggesting potential outperformance in the near future [9].
Exploring Analyst Estimates for Hasbro (HAS) Q2 Earnings, Beyond Revenue and EPS
ZACKS· 2025-07-18 14:15
Core Insights - Hasbro (HAS) is expected to report quarterly earnings of $0.76 per share, reflecting a 37.7% decline year-over-year, with revenues forecasted at $872.98 million, down 12.3% from the previous year [1] Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised upward by 1.1%, indicating analysts' reassessment of their initial forecasts [2] - Prior to earnings releases, revisions to earnings projections are crucial for predicting investor behavior, as studies show a strong correlation between earnings estimate trends and short-term stock performance [3] Revenue Forecasts - Analysts estimate 'External Net Revenues- Entertainment' at $19.18 million, a 2% increase year-over-year [5] - 'External Net Revenues- Consumer Products' is projected to be $413.93 million, reflecting a 21.1% decrease from the prior-year quarter [5] - 'External Net Revenues- Wizards of the Coast and Digital Gaming' is expected to reach $459.57 million, indicating a 1.7% increase year-over-year [6] - The consensus for 'Wizards of the Coast and Digital Gaming Net Revenues- Tabletop Gaming' stands at $337.95 million, showing a 9.9% increase from the previous year [6] - 'Wizards of the Coast and Digital Gaming Net Revenues- Digital and Licensed Gaming' is estimated at $124.14 million, a 14% decline from the prior-year quarter [7] Operating Profit - Analysts project 'Operating profit (loss)- Wizards of the Coast and Digital Gaming' to be $185.99 million, down from $247.10 million in the previous year [7] Stock Performance - Over the past month, Hasbro shares have increased by 13.6%, outperforming the Zacks S&P 500 composite, which rose by 5.4% [7] - Currently, Hasbro holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [7]
Amphenol (APH) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
ZACKS· 2025-07-18 14:15
Core Viewpoint - Analysts project that Amphenol (APH) will report quarterly earnings of $0.66 per share, reflecting a 53.5% year-over-year increase, with revenues expected to reach $4.97 billion, a 37.6% increase from the same quarter last year [1] Earnings Estimates - There has been a 0.6% upward revision in the consensus EPS estimate for the quarter over the last 30 days, indicating analysts' reassessment of their initial forecasts [2] - Revisions to earnings projections are crucial for predicting investor behavior and are strongly linked to short-term stock price performance [3] Revenue Projections - Analysts forecast 'Net Sales- Harsh Environment Solutions' to reach $1.32 billion, a 25.7% increase year-over-year [5] - 'Net Sales- Interconnect and Sensor Systems' is projected at $1.18 billion, reflecting a 5.7% increase from the prior year [5] - 'Net Sales- Communications Solutions' is expected to reach $2.48 billion, indicating a significant year-over-year change of 71.4% [5] Operating Income Estimates - 'Operating Income- Interconnect and Sensor Systems' is expected to be $224.58 million, up from $203.30 million in the same quarter last year [6] - 'Operating Income- Communications Solutions' is projected to reach $672.65 million, compared to $350.60 million in the previous year [6] - 'Operating Income- Harsh Environment Solutions' is anticipated to be $317.77 million, an increase from $259.60 million year-over-year [7] Stock Performance - Amphenol shares have increased by 9.1% over the past month, outperforming the Zacks S&P 500 composite, which rose by 5.4% [7] - With a Zacks Rank 2 (Buy), Amphenol is expected to outperform the overall market in the near future [7]
Countdown to ServiceNow (NOW) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
ZACKS· 2025-07-18 14:15
Core Viewpoint - ServiceNow (NOW) is expected to report quarterly earnings of $3.54 per share, a 13.1% increase year-over-year, with revenues projected at $3.12 billion, reflecting an 18.8% year-over-year growth [1]. Earnings Estimates - The consensus EPS estimate has been revised down by 0.4% in the last 30 days, indicating a reassessment by analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and stock price performance [3]. Revenue Projections - Analysts estimate 'Revenues- Professional services and other' to reach $88.78 million, a 4.5% year-over-year increase [5]. - 'Revenues- Subscription' is projected to be $3.03 billion, indicating a 19.3% year-over-year growth [5]. - 'Current Remaining Performance Obligations (cRPO) - GAAP' is expected to be $10.48 billion, up from $8.78 billion a year ago [5]. - 'Remaining Performance Obligations (RPO) - GAAP' is estimated at $22.11 billion, compared to $18.60 billion from the previous year [6]. Profitability Metrics - 'Gross Profit (Non-GAAP)- Subscription' is anticipated to be $2.53 billion, an increase from $2.16 billion in the same quarter last year [6]. - 'Gross Profit (Non-GAAP)- Professional services and other' is projected at $9.05 million, down from $14.00 million year-over-year [7]. Stock Performance - ServiceNow shares have decreased by 2.3% over the past month, contrasting with a 5.4% increase in the Zacks S&P 500 composite [7].